PUBLISHER: SkyQuest | PRODUCT CODE: 1321824
PUBLISHER: SkyQuest | PRODUCT CODE: 1321824
Global Branched Stent Grafts Market size was valued at USD 280.9 million in 2021 and is poised to grow from USD 303.09 million in 2022 to USD 556.86 million by 2030, growing at a CAGR of 7.9% in the forecast period (2023-2030).
The branched stent graft was invented to treat aortic lesions. It will be used in the EVAR of pectoral aneurysm and arterial dissection, and it expands the use of the EVAR of pectoral aneurysm and arterial dissection from within the aorta to within each aorta and aorta. Increases in the number of endovascular cardiovascular disease repair (EVAR) procedures, improvements in patient care quality, and advancements in medical technology are major driving factors in the branched stent grafts market. Furthermore, the growing geriatric population, as well as the high prevalence of aortic aneurysm or abdominal aneurysm, are driving the growth of the branched stent grafts market.Branched Stent Grafts Market is segmented based on the type, application and region. Based on type, Branched Stent Grafts Market is segmented into Iliac Stent and Others. Based on application, Branched Stent Grafts Market is segmented into EVAR, FEVAR, chimney, others. Based on Region Branched Stent Grafts Market is categorized into North America; Europe, Asia Pacific, Latin America, Middle East & Africa. Driver
Increased EVAR Procedures to Bolster Market.Restraints
High Cost to Hinder Market Growth. Market Trends
Abdominal endovascular aneurysm repair (AEVAR), branched endovascular aneurysm repair (BEVAR), and thoracic endovascular aneurysm repair (TEVAR) have all become standard treatments for aneurysms. The majority of people choose these procedures because they are safe, effective, less expensive, and reduce operative time. The success of these procedures is heavily reliant on the use of image guidance techniques such as X-rays.